#BEGIN_DRUGCARD DB04487

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H15NO2

# Chemical_IUPAC_Name:
(2R)-4-methyl-2-(methylamino)pentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Methylleucine

# HET_ID:
MLE

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H15NO2/c1-5(2)4-6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t6-/m1/s1

# InChI_Key:
InChIKey=XJODGRWDFZVTKW-ZCFIWIBFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4487

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
145.1995

# Molecular_Weight_Mono:
145.110278729

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LV9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.4

# Predicted_LogS:
-0.62

# Predicted_Water_Solubility:
3.50e+01 g/l

# Primary_Accession_No:
DB04487

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6951123

# PubChem_Substance_ID:
46504834

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02181

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CN[C@H](CC(C)C)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:23 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CXCL10

# Drug_Target_1_GenBank_ID_Gene:
X02530

# Drug_Target_1_GenBank_ID_Protein:
33918

# Drug_Target_1_GeneCard_ID:
CXCL10

# Drug_Target_1_Gene_Name:
CXCL10

# Drug_Target_1_Gene_Sequence:
>297 bp
ATGAATCAAACTGCGATTCTGATTTGCTGCCTTATCTTTCTGACTCTAAGTGGCATTCAA
GGAGTACCTCTCTCTAGAACCGTACGCTGTACCTGCATCAGCATTAGTAATCAACCTGTT
AATCCAAGGTCTTTAGAAAAACTTGAAATTATTCCTGCAAGCCAATTTTGTCCACGTGTT
GAGATCATTGCTACAATGAAAAAGAAGGGTGAGAAGAGATGTCTGAATCCAGAATCGAAG
GCCATCAAGAATTTACTGAAAGCAGTTAGCAAGGAAATGTCTAAAAGATCTCCTTAA

# Drug_Target_1_General_Function:
Involved in chemokine activity

# Drug_Target_1_General_References:
10233762	Tensen CP, Flier J, Van Der Raaij-Helmer EM, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R: Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol. 1999 May;112(5):716-22.
11559369	Hensbergen PJ, van der Raaij-Helmer EM, Dijkman R, van der Schors RC, Werner-Felmayer G, Boorsma DM, Scheper RJ, Willemze R, Tensen CP: Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity. Eur J Biochem. 2001 Sep;268(18):4992-9.
12173928	Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD: The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry. 2002 Aug 20;41(33):10418-25.
3925348	Luster AD, Unkeless JC, Ravetch JV: Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985 Jun 20-26;315(6021):672-6.
8423327	Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J: Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993 Feb 1;150(3):1000-10.

# Drug_Target_1_HGNC_ID:
HGNC:10637

# Drug_Target_1_HPRD_ID:
00930

# Drug_Target_1_ID:
1209

# Drug_Target_1_Locus:
4q21

# Drug_Target_1_Molecular_Weight:
10881

# Drug_Target_1_Name:
Small inducible cytokine B10

# Drug_Target_1_Number_of_Residues:
98

# Drug_Target_1_PDB_ID:
1O80

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00048	IL8

# Drug_Target_1_Protein_Sequence:
>Small inducible cytokine B10 precursor
MNQTAILICCLIFLTLSGIQGVPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRV
EIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-21

# Drug_Target_1_Specific_Function:
Chemotactic for monocytes and T-lymphocytes. Binds to CXCR3

# Drug_Target_1_SwissProt_ID:
P02778

# Drug_Target_1_SwissProt_Name:
CXL10_HUMAN

# Drug_Target_1_Synonyms:
10 kDa interferon- gamma-induced protein
CXCL10
Gamma-IP10
IP-10
Small inducible cytokine B10 precursor

# Drug_Target_1_Theoretical_pI:
10.62

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04487
